HCW Biologics (HCWB) News Today $0.35 -0.02 (-5.41%) Closing price 04:00 PM EasternExtended Trading$0.36 +0.01 (+1.43%) As of 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period HCW Biologics CEO to address opportunities, challenges in biomanufacturingJanuary 15, 2025 | markets.businessinsider.comHCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025January 15, 2025 | globenewswire.comHCW Biologics receives notice on failing to regain compliance from NasdaqDecember 23, 2024 | markets.businessinsider.comBroward pharma business could be delisted from stock exchangeDecember 23, 2024 | bizjournals.comHCW Announces Written Notice from NASDAQDecember 23, 2024 | baystreet.caHCW Biologics Inc. Receives Nasdaq Delisting Notice, Plans to Appeal for Continued ListingDecember 23, 2024 | quiverquant.comHCW Biologics Inc. Received NASDAQ Staff Determination LetterDecember 23, 2024 | globenewswire.comHCW Biologics Secures Strategic Agreements and Funding to Propel Growth and InnovationNovember 28, 2024 | markets.businessinsider.comHCW Biologics issues 2.55 million shares to Armistice CapitalNovember 26, 2024 | investing.comHCW Biologics Expands with New Financial AgreementsNovember 21, 2024 | markets.businessinsider.comHCW Biologics jumps on license agreement for immunotherapeutic product candidateNovember 19, 2024 | msn.comHCW Biologics licenses proprietary preclinical molecule to WY BiotechNovember 19, 2024 | markets.businessinsider.comWhy Is Penny Stock HCW Biologics Surging On Monday?November 19, 2024 | finance.yahoo.comHCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNovember 18, 2024 | globenewswire.comHCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNovember 18, 2024 | globenewswire.comHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 16, 2024 | finanznachrichten.deHCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 14, 2024 | globenewswire.comHCW Biologics (NASDAQ:HCWB) Stock, Insider Trading ActivityOctober 1, 2024 | benzinga.comHCW Biologics (NASDAQ:HCWB) Stock Quotes, Forecast and News SummaryOctober 1, 2024 | benzinga.comAC Immune SA (IMR.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comHCWB HCW Biologics Inc.August 25, 2024 | seekingalpha.comHCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionAugust 23, 2024 | globenewswire.comHCW Biologics, Inc: HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 15, 2024 | finanznachrichten.deHCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 14, 2024 | globenewswire.comHCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024May 15, 2024 | investorplace.comHCW Biologics Warns of Ability to Continue Operating Without Additional FundsMay 15, 2024 | marketwatch.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15, 2024 | markets.businessinsider.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15, 2024 | globenewswire.comHCW Biologics Inc. (NASDAQ:HCWB) Short Interest UpdateHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Based on an average daily volume of 16,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.1% of the company's stock are short sold.April 2, 2024 | marketbeat.comHCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023April 2, 2024 | investorplace.comHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsApril 1, 2024 | globenewswire.comHCW Biologics Inc. (NASDAQ:HCWB) Sees Large Growth in Short InterestHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 24,000 shares, an increase of 445.5% from the February 14th total of 4,400 shares. Based on an average daily volume of 14,500 shares, the short-interest ratio is presently 1.7 days. Currently, 0.2% of the company's stock are sold short.March 12, 2024 | marketbeat.comRebecca Byam Bought 122% More Shares In HCW BiologicsFebruary 24, 2024 | finance.yahoo.comSeveral Insiders Invested In HCW Biologics Flagging Positive NewsJanuary 25, 2024 | finance.yahoo.comHCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment OpportunityNovember 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)November 15, 2023 | markets.businessinsider.comHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | finanznachrichten.deHCW Biologics GAAP EPS of -$0.14, revenue of $174.77MNovember 14, 2023 | msn.comHCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | finance.yahoo.comADMA Biologics Inc ADMANovember 11, 2023 | morningstar.comHCW Biologics Inc HCWBNovember 11, 2023 | morningstar.comPromising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW BiologicsNovember 11, 2023 | markets.businessinsider.comInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNovember 8, 2023 | finance.yahoo.comSamsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companiesNovember 6, 2023 | finance.yahoo.comMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingNovember 1, 2023 | finance.yahoo.comHCW Biologics director Gary Winer buys shares worth $3.3k - filingSeptember 21, 2023 | seekingalpha.comInsider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics IncSeptember 16, 2023 | finance.yahoo.comInsider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics IncSeptember 9, 2023 | finance.yahoo.comHCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023September 6, 2023 | finance.yahoo.comInsider Stock Buying Reaches US$845k On HCW BiologicsAugust 18, 2023 | finance.yahoo.com Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address HCWB Media Mentions By Week HCWB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼0.440.57▲Average Medical News Sentiment HCWB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼20▲HCWB Articles Average Week Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Outlook Therapeutics News Today IO Biotech News Today Repare Therapeutics News Today PDS Biotechnology News Today Shattuck Labs News Today Ovid Therapeutics News Today Celularity News Today Xilio Therapeutics News Today Spero Therapeutics News Today Invivyd News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCWB) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
